[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"adrenal-venous-sampling\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:adrenal-venous-sampling":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100612338","china-adrenal-venous-sampling-investigation-100612338",false,"NCT07252284","CHina Adrenal Venous saMPling InvestigatiON","China Adrenal Venous Sampling Investigation: A National Multicenter Study","CHAMPION","Inclusion Criteria:\n\n1. Patients with confirmed primary aldosteronism;\n2. Patients undergoing adrenal venous sampling for subtype classification of primary aldosteronism.\n\nExclusion Criteria:\n\n1. Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months；\n2. An estimated glomerular filtration rate \\\u003C45 ml\u002Fmin\u002F1.73 m2, or serum creatinine \\>176 μmol\u002FL；\n3. Patients who refuse adrenalectomy;\n4. Suspected of having an adrenocortical carcinoma;\n5. Allergy to contrast agent;\n6. Pregnant, nursing, or planning to become pregnant","ALL","18 Years",{"count":20,"type":21},5000,"ESTIMATED","5 Years","OBSERVATIONAL","Primary aldosteronism (PA) is a major cause of secondary hypertension, yet its optimal diagnosis and management remain challenging. This study comprehensively evaluates adrenal venous sampling (AVS), addressing key clinical, technical, and methodological issues, and aims to clarify the relationship between AVS-guided management and long-term clinical and biochemical outcomes to optimize patient care and prognosis.",[26,27,28],"Hyperaldosteronism","Adrenal Venous Sampling","Adrenalectomy",[30,26,31,32,33],"Adrenal venous sampling","Antecubital approach","Femoral approach","Main adverse cardiovascular events","RECRUITING","2025-11-19",{"date":37,"type":38},"2025-11-26","ACTUAL",{"date":40,"type":38},"2025-05-01",{"date":42,"type":21},"2029-08-31",{"name":44,"class":45},"Chinese Academy of Medical Sciences, Fuwai Hospital","OTHER",76]